Neonax (AIO-PAK-0313): Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: A phase II study of the AIO Pancreatic Cancer Group

被引：0
|
作者：
Ettrich, Thomas Jens
Berger, Andreas W.
Muche, Rainer
Lutz, Manfred P.
Prasnikar, Nicole
Uhl, Waldemar
Tannapfel, Andrea
Heinemann, Volker
Seufferlein, Thomas
机构：
[1] Univ Ulm, Dept Internal Med 1, D-89069 Ulm, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany
[3] Caritasklinikum, Saarbrucken, Germany
[4] Klinikum Ludwigsburg, Ludwigsburg, Germany
[5] Ruhr Univ Bochum, Dept Surg, Bochum, Germany
[6] Ruhr Univ Bochum, Dept Pathol, Bochum, Germany
[7] Univ Munich, Klinikum Grosshadern, Dept Med Oncol, D-80539 Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.tps497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS497
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
    Thomas J. Ettrich
    Andreas W. Berger
    Lukas Perkhofer
    Severin Daum
    Alexander König
    Andreas Dickhut
    Uwe Wittel
    Kai Wille
    Michael Geissler
    Hana Algül
    Eike Gallmeier
    Jens Atzpodien
    Marko Kornmann
    Rainer Muche
    Nicole Prasnikar
    Andrea Tannapfel
    Anke Reinacher-Schick
    Waldemar Uhl
    Thomas Seufferlein
    BMC Cancer, 18
  • [2] Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
    Ettrich, Thomas J.
    Berger, Andreas W.
    Perkhofer, Lukas
    Daum, Severin
    Koenig, Alexander
    Dickhut, Andreas
    Wittel, Uwe
    Wille, Kai
    Geissler, Michael
    Alguel, Hana
    Gallmeier, Eike
    Atzpodien, Jens
    Kornmann, Marko
    Muche, Rainer
    Prasnikar, Nicole
    Tannapfel, Andrea
    Reinacher-Schick, Anke
    Uhl, Waldemar
    Seufferlein, Thomas
    BMC CANCER, 2018, 18
  • [3] NEONAX: NEOADJUVANT PLUS ADJUVANT OR ONLY ADJUVANT NAB-PACLITAXEL PLUS GEMCITABINE FOR RESECTABLE PANCREATIC CANCER: A PHASE II STUDY OF THE AIO PANCREATIC CANCER GROUP
    Thomas, Ettrich
    Andreas, Berger
    Rainer, Muche
    Manfred, Lutz
    Nicole, Prasnikar
    Waldemar, Uhl
    Andrea, Tannapfel
    Volker, Heinemann
    Thomas, Seufferlein
    ANNALS OF ONCOLOGY, 2014, 25 : 85 - 85
  • [4] adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer, a phase II study of the AIO pancreatic cancer group (AIO-PAK-0313)-Safety interim analysis
    Uhl, Waldemar
    Ettrich, Thomas Jens
    Reinacher-Schick, Anke C.
    Alguel, Hana
    Friess, Helmut
    Kornmann, Marko
    Koenig, Alexander
    Ghadimi, Michael
    Wittel, Uwe A.
    Gallmeier, Eike
    Wille, Kai
    Geissler, Michael
    Schimanski, Carl Christoph
    Prasnikar, Nicole
    Tannapfel, Andrea
    Perkhofer, Lukas
    Berger, Andreas W.
    Seufferlein, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] NEONAX: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer-A phase II study of the AIO Pancreatic Cancer Group.
    Ettrich, Thomas Jens
    Berger, Andreas W.
    Muche, Rainer
    Lutz, Manfred P.
    Prasnlkar, Nicole
    Uhl, Waldemar
    Tannapfel, Andrea
    Heinemann, Volker
    Soufferlein, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)da randomized phase II trial of the AIO pancreatic cancer group
    Seufferlein, T.
    Uhl, W.
    Kornmann, M.
    Alguel, H.
    Friess, H.
    Koenig, A.
    Ghadimi, M.
    Gallmeier, E.
    Bartsch, D. K.
    Lutz, M. P.
    Metzger, R.
    Wille, K.
    Gerdes, B.
    Schimanski, C. C.
    Graupe, F.
    Kunzmann, V.
    Klein, I.
    Geissler, M.
    Staib, L.
    Waldschmidt, D.
    Bruns, C.
    Wittel, U.
    Fichtner-Feigl, S.
    Daum, S.
    Hinke, A.
    Blome, L.
    Tannapfel, A.
    Kleger, A.
    Berger, A. W.
    Kestler, A. M. R.
    Schuhbaur, J. S.
    Perkhofer, L.
    Tempero, M.
    Reinacher-Schick, A. C.
    Ettrich, T. J.
    ANNALS OF ONCOLOGY, 2023, 34 (01) : 91 - 100
  • [7] Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
    Seufferlein, T.
    Uhl, W.
    Alguel, H.
    Friess, H.
    Kornmann, M.
    Koenig, A. O.
    Ghadimi, M.
    Gress, T. M.
    Lutz, M. P.
    Wille, K.
    Schimanski, C.
    Kunzmann, V.
    Berger, A.
    Schuhbaur, J.
    Perkhofer, L.
    Blome, L.
    Tannapfel, A.
    Tempero, M. A.
    Reinacher-Schick, A.
    Ettrich, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1333 - S1333
  • [8] Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Quality of life results of the randomized phase II AIO-NEONAX trial
    Ettrich, Thomas J.
    Buchholz, Sina
    Uhl, Waldemar
    Kornmann, Marko
    Algul, Hana
    Friess, Helmut
    Konig, Alexander-Otto
    Ghadimi, Michael
    Gallmeier, Eike
    Bartsch, Detlef K.
    Lutz, Manfred P.
    Metzger, Ralf
    Wille, Kai
    Gerdes, Bertold
    Schimanski, Carl C.
    Graupe, Florian
    Kunzmann, Volker
    Klein, Ingo
    Geissler, Michael
    Staib, Ludger
    Waldschmidt, Dirk
    Bruns, Christiane
    Wittel, Uwe A.
    Fichtner-Feigl, Stefan
    Daum, Severin
    Berger, Andreas
    Kestler, Angelika
    Schuhbaur, Jasmin
    Schutz, Juliane
    Perkhofer, Lukas
    Reinacher-Schick, Anke
    Seufferlein, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 77 - 78
  • [9] Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Updated final results of the randomized phase II AIO-NEONAX trial.
    Ettrich, Thomas Jens
    Uhl, Waldemar
    Kornmann, Marko
    Alguel, Hana
    Friess, Helmut
    Koenig, Alexander
    Gallmeier, Eike
    Lutz, Manfred P.
    Wille, Kai
    Schimanski, Carl Christoph
    Kunzmann, Volker
    Geissler, Michael
    Waldschmidt, Dirk
    Daum, Severin
    Blome, Lisa
    Tannapfel, Andrea
    Perkhofer, Lukas
    Tempero, Margaret A.
    Reinacher Schick, Anke C.
    Seufferlein, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Perioperative or adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Quality of life results of the randomized phase II AIO-NEONAX trial.
    Buchholz, Sina
    Ettrich, Thomas Jens
    Uhl, Waldemar
    Kornmann, Marko
    Algul, Hana
    Friess, Helmut
    Koenig, Alexander
    Gallmeier, Eike
    Lutz, Manfred P.
    Wille, Kai
    Schimanski, Carl Christoph
    Kunzmann, Volker
    Geissler, Michael
    Waldschmidt, Dirk
    Daum, Severin
    Perkhofer, Lukas
    Reinacher-Schick, Anke C.
    Seufferlein, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 694 - 694
12345